ERBB2 and breast carcinoma: For patients with late-stage breast cancer or patients with unresectable tumors, traditional endocrine therapy and chemotherapy are used concerning the status of several important biomarkers including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).